ConductScience.org, home

Paper41376134

Plasma P-tau217, GFAP, and NfL as biomarkers for Alzheimer's disease: role in disease stratification, pathological progression, and cognitive decline.

Pan FF and 7 others. Alzheimers Dement, 2025. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Plasma P-tau217, GFAP, and NfL as biomarkers for Alzheimer's disease: role in disease stratification, pathological progression, and cognitive decline. Papers, record 41376134. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41376134

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Plasma P-tau217, GFAP, and NfL as biomarkers for Alzheimer's disease: role in disease stratification, pathological progression, and cognitive decline.
PubMed
Journal
Alzheimers Dement
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
3.46, provisional
iCite
Revised in PubMed
2026-05-20
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pan FFFeng-Feng
2Huang LLin
3Wang YYing
4Huang QQi
5Guan YHYi-Hui
6Li YHYue-Hua
7Xie FFang
8Guo QHQi-Hao

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
tau ProteinsMajor topic
Alzheimer DiseaseMajor topic
Neurofilament ProteinsMajor topic
Glial Fibrillary Acidic ProteinMajor topic
Cognitive DysfunctionMajor topic
Humans
Biomarkers
Male
Female
Disease Progression
Aged
Amyloid beta-Peptides
Hippocampus
Phosphorylation
Atrophy
Cohort Studies
Aged, 80 and over

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82171198National Natural Science Foundation of ChinaPubMed
202440010Shanghai Municipal Commission of Health Research ProjectPubMed
202440009Shanghai Municipal Commission of Health Research ProjectPubMed

Source PubMed

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT07917182Chinese University-Alzheimer's Disease With Vascular and Other Co-pathology: Towards Actionable Neuro-Cognitive-Omic Evaluations (CU-ADVANCE)Background

Source ClinicalTrials.gov

Download CSV of trials

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133585983Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology.Acta Neuropathol2021https://conductscience.org/library/papers/33585983PubMed
227996103Validation of the Chinese Version of Montreal Cognitive Assessment Basic for Screening Mild Cognitive Impairment.J Am Geriatr Soc2016https://conductscience.org/library/papers/27996103PubMed
335618838Performance of plasma phosphorylated tau 181 and 217 in the community.Nat Med2022https://conductscience.org/library/papers/35618838PubMed
430611668Astrocyte Biomarkers in Alzheimer's Disease.Trends Mol Med2019https://conductscience.org/library/papers/30611668PubMed
534838239Blood-based biomarkers for Alzheimer's disease: towards clinical implementation.Lancet Neurol2022https://conductscience.org/library/papers/34838239PubMed
67706627ADL dependence and medical conditions in Chinese older persons: a population-based survey in Shanghai, China.J Am Geriatr Soc1995https://conductscience.org/library/papers/7706627PubMed
730422768Signs and Artifacts in Amyloid PET.Radiographics2018https://conductscience.org/library/papers/30422768PubMed
841376134Plasma P-tau217, GFAP, and NfL as biomarkers for Alzheimer's disease: role in disease stratification, pathological progression, and cognitive decline.Alzheimers Dement2025https://conductscience.org/library/papers/41376134PubMed
934099648A multicentre validation study of the diagnostic value of plasma neurofilament light.Nat Commun2021https://conductscience.org/library/papers/34099648PubMed
1037198279Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies.Nat Aging2023https://conductscience.org/library/papers/37198279PubMed
1125348064Primary age-related tauopathy (PART): a common pathology associated with human aging.Acta Neuropathol2014https://conductscience.org/library/papers/25348064PubMed
1235908251The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease.Alzheimers Dement2022https://conductscience.org/library/papers/35908251PubMed
1331564456Alzheimer Disease: An Update on Pathobiology and Treatment Strategies.Cell2019https://conductscience.org/library/papers/31564456PubMed
1436175137A Visual Interpretation Algorithm for Assessing Brain Tauopathy with 18F-MK-6240 PET.J Nucl Med2023https://conductscience.org/library/papers/36175137PubMed
1533257949Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.Brain2021https://conductscience.org/library/papers/33257949PubMed
1633165506Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease.JAMA Neurol2021https://conductscience.org/library/papers/33165506PubMed
1732722745Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.JAMA2020https://conductscience.org/library/papers/32722745PubMed
1837357299Chinese Preclinical Alzheimer's Disease Study (C-PAS): Design and Challenge from PET Acceptance.J Prev Alzheimers Dis2023https://conductscience.org/library/papers/37357299PubMed
1934309632Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes.JAMA Neurol2021https://conductscience.org/library/papers/34309632PubMed
2031009028Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.JAMA Neurol2019https://conductscience.org/library/papers/31009028PubMed

See all 34 referencesDownload CSV of references

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42952670Peripheral hematological inflammatory signatures in the amyloid-defined Alzheimer's disease continuum: associations with disease stage, cognitive function, and astroglial activation.Front Immunol2026https://conductscience.org/library/papers/42952670PubMed
42948835Blood-Based Biomarkers in Alzheimer's Disease: Advances in Detection Technologies and Clinical Applications.Aging Med (Milton)2026https://conductscience.org/library/papers/42948835PubMed
42923225Noninvasive diagnosis of Alzheimer's disease: a review of emerging biomarkers and multimodal approaches.Front Cell Dev Biol2026https://conductscience.org/library/papers/42923225PubMed
42903321Reduced serum LEFTY2 and disease-dependent biomarker associations in Alzheimer's disease: an exploratory study.Front Aging Neurosci2026https://conductscience.org/library/papers/42903321PubMed
42897700A Two-Stage Plasma Biomarker Algorithm Reduces Amyloid PET Use and the p-Tau217 Gray Zone.Ann Clin Transl Neurol2026https://conductscience.org/library/papers/42897700PubMed
42888952Integration of neuroimaging signatures of aging and Alzheimer's with fluid biomarkers.Alzheimers Dement2026https://conductscience.org/library/papers/42888952PubMed
42882500Targeting Pro-Inflammatory Interleukin-1 Beta Signaling to Modulate Neuroinflammatory Processes Associated with Cognitive Decline in Dementia with Lewy Bodies.Cells2026https://conductscience.org/library/papers/42882500PubMed
42877469A multivariate plasma pathology-cognition axis reveals biologically anchored residual cognitive heterogeneity across the Alzheimer's disease clinical spectrum.J Alzheimers Dis Rep2026https://conductscience.org/library/papers/42877469PubMed
42857403Residualized occipital amyloid burden and plasma biomarker profiles in relation to ARIA-E during anti-amyloid treatment.Alzheimers Dement (Amst)2026https://conductscience.org/library/papers/42857403PubMed
42827967Short-chain fatty acid-producing commensals: Key modulators of AD neuroinflammation via the microbiota-gut-brain axis.Curr Res Microb Sci2026https://conductscience.org/library/papers/42827967PubMed
42812991AAV-mediated gene therapy for Alzheimer's disease: neuroprotective mechanisms and translational challenges.Front Aging Neurosci2026https://conductscience.org/library/papers/42812991PubMed
42719511Plasma GFAP and language-network tau mediate the effect of amyloid burden on semantic fluency: A mediation analysis.Alzheimers Dement (Amst)2026https://conductscience.org/library/papers/42719511PubMed
42698737Translating blood-based biomarkers into Alzheimer's disease clinical practice: screening, diagnosis, and longitudinal monitoring.Front Aging Neurosci2026https://conductscience.org/library/papers/42698737PubMed
42593791Blood Biomarkers of Alzheimer Disease and Rates of Global and Domain-Specific Cognitive Decline.JAMA Netw Open2026https://conductscience.org/library/papers/42593791PubMed
42542440Advancing Alzheimer's disease research in China: insights, innovations, and future directions from the chinese preclinical Alzheimer's disease study (CPAS).Mol Psychiatry2026https://conductscience.org/library/papers/42542440PubMed
42534839Anemia, iron deficiency, and blood biomarkers for Alzheimer disease: clinical interpretation and dementia risk stratification.Front Nutr2026https://conductscience.org/library/papers/42534839PubMed
42449841Analytical Performance and Evaluation in Clinical Cohorts of a Fully Automated Immunoassay for Plasma Glial Fibrillary Acidic Protein.Diagnostics (Basel)2026https://conductscience.org/library/papers/42449841PubMed
42434607Comparison of a multi-analyte algorithmic immunoassay blood test with immunoprecipitation mass spectrometry for the detection of amyloid pathology.Alzheimers Dement (Amst)2026https://conductscience.org/library/papers/42434607PubMed
42385111Neuropsychological Profile and Cognitive Trajectories of Patients With Biomarker Evidence of Alzheimer Disease or Dementia With Lewy bodies.Neurology2026https://conductscience.org/library/papers/42385111PubMed
42356806Enhancing Early Detection of Alzheimer's Disease: An Ensemble Model for Multi-Domain Cognitive Assessment Using Voice and Video.Sensors (Basel)2026https://conductscience.org/library/papers/42356806PubMed

See all 23 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APP351PubTator's text mininghttps://conductscience.org/library/genes/351NCBI Gene
GFAP2670PubTator's text mininghttps://conductscience.org/library/genes/2670NCBI Gene
MAPT4137PubTator's text mininghttps://conductscience.org/library/genes/4137NCBI Gene
NEFL4747PubTator's text mininghttps://conductscience.org/library/genes/4747NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41376134

GET https://conductscience.org/api/papers/v1/41376134/references?page=2